ANX
Adventrx Pharmaceuticals
Biopharmaceutical company developing drugs for the treatment of vascular, infectious and oncologic diseases
CUSIP: 00764X103HealthcareUS1 holder
Adventrx Pharmaceuticals
Biopharmaceutical company developing drugs for the treatment of vascular, infectious and oncologic diseases
No Schedule 13D or 13G filings recorded.